Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s435, 2024. DOI: 10.25251/skin.8.supp.435. Disponível em: https://skin.dermsquared.com/skin/article/view/3112. Acesso em: 18 may. 2025.